Ginkgo Bioworks shares rise 2.50% premarket after announcing strategic partnership for AI-driven drug discovery.

Ginkgo Bioworks Holdings, Inc. rose 2.50% in premarket trading, driven by the announcement of a new strategic partnership between its Datapoints offering, Inductive Bio, and Tangible Scientific. This collaboration aims to make AI-driven lab-in-the-loop drug discovery broadly accessible across the industry, combining high-throughput experimental workflows, streamlined compound management, and predictive chemistry AI models into a seamless integrated service. This partnership is expected to help scientists design better drugs with fewer resources, which is likely to have a positive impact on the company's stock performance.